The Government of Brazil has reportedly announced that the country has detected its first-ever confirmed case of the South African variant. The new case points towards a fresh new sign of danger for a nation that is already being ravaged by the pandemic and reporting
In a recent move to accelerate the availability of COVID-19 vaccines, all the African Union member states are slated to gain access to nearly 220 million doses of the Johnson & Johnson (J&J) single-dose coronavirus vaccine, with the ability to order an extra 1
The clinical trial includes evaluating tolerability, immunogenicity, and safety of two intramuscular vaccinations for HIV-infected children
U.S. headquartered clinical-stage biopharmaceutical company, Curevo Vaccin
A business lobby group in South Africa has reportedly called on the government to shift the focus of its vaccine program on the elderly as well as the vulnerable, to avoid hospitals being flooded with patients from a third COVID-19 wave.
Throughout Southeast Asia and Africa, several aid groups and governments agencies are joining the World Health Organization’s call for pharmaceutical enterprises to share their respective COVID-19 vaccine patent information in an effort to address the yawning global vaccine shortfall more e
Data from a recent study suggests that the Pfizer/BioNTech COVID-19 vaccine might be less effective for people that are obese. Researchers in Italy have discovered that, as compared to healthy individuals, obese healthcare workers were able to produce just about half the total amount of antibodie
South Africa is nearing plans to inject $712 million to vaccinate 67% of its population as to control the spread of the coronavirus in the country as well as to revive the economy which had faced a slopping decline of 7.2% last year.
South Africa was already in the midst of an economy rece
Renowned American biotech firm, Moderna, has reportedly announced that it is currently working with a number of government scientists in South Africa to study the efficacy of an experimental booster dose designed specifically to target the South African strain of the coronavirus.
Driven by the need to develop an effective frontline cell therapy treatment for multiple myeloma, Cartesian Therapeutics, a clinical-stage biopharmaceutical company specializing in mRNA-engineered cell therapy, has announced the initiation of a Phase 2a clinical trial of Descartes-11, a new mRNA